We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




First-Of-Its-Kind AI-Driven Brain Imaging Platform to Better Guide Stroke Treatment Options

By HospiMedica International staff writers
Posted on 05 Mar 2025

Each year, approximately 800,000 people in the U. More...

S. experience strokes, with marginalized and minoritized groups being disproportionately affected. Strokes vary in terms of size and location within the brain, making recovery studies particularly challenging. Each survivor faces different difficulties depending on where the stroke occurred and its severity, such as weakness on one side of the body or difficulty speaking. Some treatments designed to aid recovery may only benefit individuals with strokes in specific areas of the brain. Until now, it has been difficult to quickly identify individuals based on the size and location of their stroke in order to test these treatments. Now, a new artificial intelligence (AI)-driven brain imaging platform is expected to significantly improve treatment guidance and transform stroke recovery research.

A group of stroke physician-scientists at Georgetown University Medical Center (Washington, D.C., USA) has launched the Acute Stroke Imaging Database (AStrID), an initiative that scans MRI images to automatically identify the type and location of strokes in approximately 5,000 acute stroke cases seen annually at the MedStar Health system (Columbia, MD, USA). MedStar Health serves a diverse patient population, representing a wide range of socioeconomic, cultural, and racial backgrounds from 10 hospitals in Maryland, Washington, D.C., and Virginia. This makes it an ideal sample group to reflect the U.S. population. AStrID is part of a larger stroke registry that reviews electronic medical records of stroke patients to aid in research efforts. By allowing researchers to group stroke survivors based on the specifics of their strokes, AStrID enables the identification of the most appropriate clinical trials and treatments for each patient, thereby enhancing the reliability of stroke recovery studies.

The AStrID development process began with hundreds of training images in which the researchers manually identified the location of the strokes. They then fed this information into the AStrID learning algorithm, which, based on these training sets, can detect stroke locations in new MRI images. Using the platform’s search tool, researchers can pinpoint images in AStrID that display strokes in specific brain regions. In the next year, the researchers aim to include up to 20,000 stroke images in AStrID, potentially making it the largest stroke imaging repository globally. To protect patient confidentiality, AStrID removes all identifying details from the MRIs before processing them, storing only the digital images that mark the stroke locations, not the actual MRI scans. These images are kept separately from the electronic medical records within the broader stroke registry, with access to the two being restricted and linked only through anonymized codes.

The research team’s primary focus is on helping patients recover language abilities post-stroke. Approximately one-third of stroke survivors experience aphasia, a condition that impairs language use. After a stroke, the brain has the capacity to reorganize itself and form new connections, a process known as brain plasticity, which enables recovery of lost functions over time. Enhancing brain plasticity could improve recovery from aphasia, but the pattern of this plasticity varies based on the size and location of each stroke. With AStrID, the researchers can identify groups of patients with similar stroke profiles, helping them uncover previously hidden patterns of brain plasticity that could potentially be targeted by new treatments to enhance recovery.

“Disparities in access to services affect every phase of stroke care,” said Peter E. Turkeltaub, MD, PhD, director of the Cognitive Recovery Lab at Georgetown University and the Aphasia Clinic at MedStar National Rehabilitation Hospital. “AStrID and the broader stroke registry can help us understand how these disparities affect outcomes. We can identify groups of people who we’d expect to have similar recoveries because they have very similar strokes, and then assess if access to rehabilitation or other stroke services changes their recovery. That will help us find the people who would benefit most from better stroke services to improve equity and outcomes.”

Related Links:
Georgetown University Medical Center
MedStar Health


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Blood Bank Refrigerator
MBR-705GR-PE
Infrared Digital Thermometer
R1B1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.